Skip to main content
Oncotarget logoLink to Oncotarget
. 2018 Feb 23;9(15):12534. doi: 10.18632/oncotarget.24557

Correction: miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma

Emanuela Minna 1, Paola Romeo 1, Matteo Dugo 2, Loris De Cecco 2, Katia Todoerti 3, Silvana Pilotti 4, Federica Perrone 4, Ettore Seregni 5, Luca Agnelli 6, Antonino Neri 6,7, Angela Greco 1, Maria Grazia Borrello 1
PMCID: PMC5844767  PMID: 29552331

This article has been corrected: The updated Grant information is provided below:

GRANT SUPPORT

This work was supported by Associazione Italiana per la Ricerca sul Cancro (AIRC, Grant IG10366 to M.G. Borrello and Grant IG13307 to E. Seregni), by Ministero della Salute (Ricerca Finalizzata 2013 RF-2013-02354985) and in part by funds obtained through an Italian law that allows taxpayers to allocate 0.5 percent share of their income tax contribution to a research institution of their choice.

Original article: Oncotarget. 2016; 7:12731-12747. https://doi.org/10.18632/oncotarget.7262


Articles from Oncotarget are provided here courtesy of Impact Journals, LLC

RESOURCES